|
Biologics Penetration of Early Lines of Therapy in Psoriasis, Crohn’s Disease and Rheumatoid Arthritis: Implications for Existing and Emerging Brands
— A Webinar from Decision Resources
Based on our three Treatment Algorithms reports, Treatment Algorithms in Psoriasis, Treatment Algorithms in Crohn’s Disease and Treatment Algorithms in Rheumatoid Arthritis, Decision Resources is offering an exclusive, in-depth webinar entitled Biologics Penetration of Early Lines of Therapy in Psoriasis, Crohn’s Disease and Rheumatoid Arthritis: Implications for Existing and Emerging Brands. Because this webinar will feature major report findings on each of the abovementioned reports, you must have purchased ONE of these reports in order to attend the session.
Please contact us to learn how you can purchase one of these Treatment Algorithms reports and attend the webinar.
Based on our analysis of patient-level claims data for these three immune diseases, we find that early-line use of biologics differs depending on the disease. Furthermore, a longitudinal analysis of these data show that the speed with which biologics have captured share from small-molecule agents varies. For marketers of agents in these diseases and for companies planning to launch into these markets, biologics positioning in lines of therapy is critical to forecasting patient flows to your agent, potential uptake and competitive positioning in each market.
This webinar, presented by Madhuri Borde, Ph.D., Project Director for Treatment Algorithms at Decision Resources, will discuss:
- Current penetration of biologics by disease and how these agents’ positioning in treatment has changed over time
- Physician predictions of biologics penetration (both current and emerging brands) over the
next two years
- Implications for brands already in these diseases
- Implications for companies planning to launch into these markets
Dr. Borde will conduct a live question and answer session after the presentation.
Webinar Information
Biologics Penetration of Early Lines of Therapy in Psoriasis, Crohn’s Disease and Rheumatoid Arthritis: Implications for Existing and Emerging Brands
November 19, 2008 at 10 a.m. U.S. Eastern Time, 4 p.m. Central European Time (Paris).
To learn how you can purchase one of these Treatment Algorithms reports and attend this webinar, please contact:
In North America — Steve Silvestro at 781-296-2626 or ssilvestro@dresources.com
In Europe — Kaj van Langendonck at +32-2-357-06-14 or kvanlangendonck@decisionresources.be
In Japan — Makiko Yoshimoto at +81-3-5401-2615 or makiko@dresources.jp
|
